{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:24:15Z","timestamp":1791926655018,"version":"4.3.4"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The impact of adult-use cannabis legalization and subsequent commercialization (ie, increasing store and product access) on hospitalizations in Canada is unclear.<\/jats:p><\/jats:sec>Objectives<\/jats:title>To examine changes in overall and subtypes of hospitalizations due to cannabis and associated factors following legalization in Canada and to compare changes between provinces.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This repeated cross-sectional analysis included all acute hospitalizations for individuals aged 15 to 105 years in Canada\u2019s 4 most populous provinces (Ontario, Quebec, Alberta and British Columbia, population 26.9 million individuals in 2018). Data were obtained from routinely collected health administrative databases. Immediate and gradual changes in the age- and sex-standardized rates of hospitalizations due to cannabis were compared using an interrupted time series design over 3 time periods: prelegalization (January 2015 to September 2018), legalization with product and store restrictions (October 2018 to February 2020), and commercialization, which overlapped with the COVID-19 pandemic (March 2020 to March 2021).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Rates of hospitalizations due to cannabis per 100\u202f000 individuals and per 1000 all-cause hospital admissions.<\/jats:p><\/jats:sec>Results<\/jats:title>There were 105\u202f203 hospitalizations due to cannabis over the 7-year study period, 69\u202f192 of which (65.8%) were among male individuals, and 34\u202f678 (33%) of which were among individuals aged 15 to 24 years. Overall, the age- and sex-standardized rate of hospitalizations increased 1.62 times between January 2015 (3.99 per 100\u202f000 individuals) and March 2021 (6.46 per 100\u202f000 individuals). The largest relative increase in hospitalizations was for cannabis-induced psychosis (rate ratio, 1.40; 95% CI, 1.34 to 1.47 during the commercialization period relative to the prelegalization period). Nationally, legalization with restrictions was associated with a gradual monthly decrease of \u22120.06 (95% CI \u22120.08 to \u22120.03) in hospitalizations due to cannabis per 100\u202f000 individuals. Commercialization and the COVID-19 pandemic were associated with an immediate increase of 0.83 (95% CI, 0.30 to 1.30) hospitalizations due to cannabis per 100\u202f000 individuals. There was provincial variation in changes, with provinces with less mature legal markets experiencing the greatest declines immediately following legalization.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This cross-sectional study found that legalization with restrictions was not associated with an increase in hospitalizations due to cannabis but commercialization was. The findings suggest that commercialization of cannabis may be associated with increases in cannabis-related health harms, including cannabis-induced psychosis.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.36113","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:31:59Z","timestamp":1696519919000},"page":"e2336113","source":"Crossref","is-referenced-by-count":48,"title":["Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada"],"prefix":"10.1001","volume":"6","author":[{"given":"Daniel T.","family":"Myran","sequence":"first","affiliation":[{"name":"Bruy\u00e8re Research Institute, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"ICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Gaudreault","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Konikoff","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Talarico","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Liccardo Pacula","sequence":"additional","affiliation":[{"name":"Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles"},{"name":"Institute for Addiction Science, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"issue":"10208","key":"zoi231040r2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0140-6736(19)31789-1","article-title":"Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.","volume":"394","author":"Hall","year":"2019","journal-title":"Lancet"},{"issue":"23","key":"zoi231040r3","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use.","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"zoi231040r4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fpsyg.2020.00833","article-title":"Unraveling the intoxicating and therapeutic effects of cannabis ingredients on psychosis and cognition.","volume":"11","author":"Colizzi","year":"2020","journal-title":"Front Psychol"},{"issue":"8","key":"zoi231040r5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/jamapsychiatry.2020.0339","article-title":"Will legalization and commercialization of cannabis use increase the incidence and prevalence of psychosis?","volume":"77","author":"Murray","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"zoi231040r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109288","article-title":"Trends and characteristics of cannabis-associated emergency department visits in the United States, 2006-2018.","volume":"232","author":"Roehler","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi231040r8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/eurpub\/cky272","article-title":"Increase in emergency department visits related to cannabis reported using syndromic surveillance system.","volume":"29","author":"Noel","year":"2019","journal-title":"Eur J Public Health"},{"issue":"9","key":"zoi231040r9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.31937","article-title":"Changes in emergency department visits for cannabis hyperemesis syndrome following recreational cannabis legalization and subsequent commercialization in Ontario, Canada.","volume":"5","author":"Myran","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi231040r10","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1111\/add.v117.7","article-title":"The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.","volume":"117","author":"Myran","year":"2022","journal-title":"Addiction"},{"issue":"6","key":"zoi231040r11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1017\/cem.2020.384","article-title":"Clearing the air: a study of cannabis-related presentations to urban Alberta emergency departments following legalization.","volume":"22","author":"Yeung","year":"2020","journal-title":"CJEM"},{"key":"zoi231040r12","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02185-x","article-title":"Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis.","author":"Myran","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"8","key":"zoi231040r13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/07067437211070650","article-title":"Associations between Canada\u2019s cannabis legalization and emergency department presentations for transient cannabis-induced psychosis and schizophrenia conditions: Ontario and Alberta, 2015-2019.","volume":"67","author":"Callaghan","year":"2022","journal-title":"Can J Psychiatry"},{"issue":"5","key":"zoi231040r14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/dar.v42.5","article-title":"Impact of Canada\u2019s cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019.","volume":"42","author":"Callaghan","year":"2023","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"zoi231040r15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/ADM.0000000000000747","article-title":"Cannabis-related hospitalizations among youth in Canada before and after cannabis legalization.","volume":"15","author":"Auger","year":"2021","journal-title":"J Addict Med"},{"issue":"1","key":"zoi231040r16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/07067437221114785","article-title":"Cannabis legalization and cannabis-related hospitalizations in Ontario, Canada.","volume":"68","author":"Kim","year":"2023","journal-title":"Can J Psychiatry"},{"issue":"2","key":"zoi231040r17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/dar.v41.2","article-title":"How has access to legal cannabis changed over time? an analysis of the cannabis retail market in Canada two years following the legalization of recreational cannabis.","volume":"41","author":"Myran","year":"2022","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"zoi231040r18","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/dar.v42.5","article-title":"Access to legal cannabis market in Canada over the four?years following non-medical cannabis legalisation.","volume":"42","author":"Myran","year":"2023","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"zoi231040r23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12874-021-01306-w","article-title":"Comparison of six statistical methods for interrupted time series studies: empirical evaluation of 190 published series.","volume":"21","author":"Turner","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"zoi231040r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109765","article-title":"Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001-2019).","volume":"244","author":"Imtiaz","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi231040r25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.drugpo.2014.09.007","article-title":"Medical marijuana programs: implications for cannabis control policy\u2013observations from Canada.","volume":"26","author":"Fischer","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"5","key":"zoi231040r29","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/dar.v42.5","article-title":"Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation.","volume":"42","author":"Myran","year":"2023","journal-title":"Drug Alcohol Rev"},{"key":"zoi231040r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103028","article-title":"Legal cannabis market shares during Canada\u2019s first year of recreational legalisation.","volume":"88","author":"Armstrong","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"5","key":"zoi231040r31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/dar.v41.5","article-title":"Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic.","volume":"41","author":"Armstrong","year":"2022","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"zoi231040r35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jadohealth.2017.12.010","article-title":"Impact of marijuana legalization in Colorado on adolescent emergency and urgent care visits.","volume":"63","author":"Wang","year":"2018","journal-title":"J Adolesc Health"},{"issue":"6","key":"zoi231040r36","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jadohealth.2021.07.028","article-title":"Trends in adolescent cannabis-related hospitalizations by state legalization laws, 2008-2019.","volume":"69","author":"Masonbrink","year":"2021","journal-title":"J Adolesc Health"},{"issue":"3","key":"zoi231040r37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/ADM.0000000000000480","article-title":"Changes in healthcare encounter rates possibly related to cannabis or alcohol following legalization of recreational marijuana in a safety-net hospital: an interrupted time series analysis.","volume":"13","author":"Calcaterra","year":"2019","journal-title":"J Addict Med"},{"issue":"2","key":"zoi231040r40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/dar.v42.2","article-title":"Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: a scoping review.","volume":"42","author":"Myran","year":"2023","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"zoi231040r41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1176\/appi.ajp.2017.17020223","article-title":"Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis.","volume":"175","author":"Starzer","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"3","key":"zoi231040r43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/schbul\/sbz102","article-title":"Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and meta-analysis.","volume":"46","author":"Murrie","year":"2020","journal-title":"Schizophr Bull"},{"key":"zoi231040r34","volume-title":"Sales and Revenue from Regulated Cannabis Products: British Columbia, October 2018-December 2020","author":"Naimi","year":"2021"},{"key":"zoi231040r1","unstructured":"Parliament of Canada. Bill C-45 the Cannabis Act2018. Accessed September 5, 2023. https:\/\/www.parl.ca\/DocumentViewer\/en\/42-1\/bill\/C-45\/royal-assent"},{"key":"zoi231040r6","unstructured":"Canadian Institute for Health Information. Hospital stays for harm caused by substance use among youth age 10 to 24. Accessed April 18, 2023. https:\/\/www.cihi.ca\/sites\/default\/files\/document\/hsu-youth-report-2019-en-web.pdf"},{"key":"zoi231040r19","unstructured":"Government of Canada. Cannabis laws and regulations. Accessed April 4, 2023. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/laws-regulations\/provinces-territories.html"},{"key":"zoi231040r20","unstructured":"Statistics Canada. Table 17-10-0009-01 Population estimates on July 1st, by age and sex. Accessed September 5, 2023. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501"},{"key":"zoi231040r21","unstructured":"Canadian Institute for Health Information. Canadian COVID-19 intervention timeline. Accessed May 22, 2023. https:\/\/www.cihi.ca\/en\/canadian-covid-19-intervention-timeline"},{"key":"zoi231040r22","unstructured":"Alliance for Healthier Communities. Non-insured clients. Accessed July 18, 2023. https:\/\/www.allianceon.org\/Non-Insured-Clients"},{"key":"zoi231040r26","unstructured":"Task Force on Cannabis Legalization and Regulation. A framework for the legalization and regulation of cannabis in Canada. Accessed September 1, 2023. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/laws-regulations\/task-force-cannabis-legalization-regulation\/framework-legalization-regulation-cannabis-in-canada.html"},{"key":"zoi231040r27","unstructured":"Evans? P. As legalization looms, pot dispensaries wrestle with whether to close now to go legit later. CBC News. Accessed February 22, 2023. https:\/\/www.cbc.ca\/news\/business\/marijuana-dispensaries-closure-legalization-1.4831521"},{"key":"zoi231040r28","unstructured":"Canadian Centre on Substance Use and Addiction. Cannabis Legalization: One Year Observations. Accessed September 5, 2023. https:\/\/www.ccsa.ca\/sites\/default\/files\/2019-10\/CCSA-Synthesis-Canada-Cannabis-Legalization-First-Year-Policy-Brief-2019-en.pdf"},{"key":"zoi231040r32","unstructured":"Canadian Institute for Health Information. Unintended consequences of COVID-19: impact on harms caused by substance use. Accessed May 26, 2021. https:\/\/www.cihi.ca\/en\/unintended-consequences-of-covid-19-impact-on-harms-caused-by-substance-use"},{"key":"zoi231040r33","unstructured":"Ontario Cannabis Store. A year in review: April 1, 2020-March 31, 2021. Accessed September 5, 2023. https:\/\/cdn.shopify.com\/s\/files\/1\/2636\/1928\/files\/OCS-InsightsReport_____2020-21.pdf?v=1625075546"},{"key":"zoi231040r38","unstructured":"Government of Canada. Cannabis market data. Accessed April 19, 2023. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/research-data\/market.html"},{"key":"zoi231040r39","unstructured":"Statistics Canada. National cannabis survey: summaries 2018-2021. Accessed April 19, 2023. https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/190207\/dq190207b-eng.htm"},{"key":"zoi231040r42","unstructured":"Government of Canada. Canadian cannabis survey 2022: summary. Accessed April 19, 2023. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/research-data\/canadian-cannabis-survey-2022-summary.html#s2"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2810194\/myran_2023_oi_231040_1695747112.84638.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:32:12Z","timestamp":1696519932000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2810194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.36113","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}